Smart Augmented White Cane and Non-Toxic Protein As Possible Treatment For Glaucoma On December 5 Show

Augmented White Cane (Stanford University - Palo Alto, CA)

Dr. Susan Quaggin (Northwestern University Feinberg School of Medicine - Chicago, IL)

Arjun Tambe, symbolic systems graduate, at Stanford University, in Palo Alto, California, explains, the relatively lightweight and inexpensive Augmented White Cane, which uses many sensors to detect and identify objects and obstacles and guide users around those obstacles.

Dr. Susan Quaggin, chief of nephrology and hypertension at Northwestern University Feinberg School of Medicine in Chicago, discusses how a non-toxic protein, Hepta-ANGPT1, tested in mice, could potentially be used a treatment for primary congenital glaucoma and open angle glaucoma.

12/5/2021 Podcast (Click Image Below)

Prozac To Treat Dry AMD and Vision Buddy Goggles To Watch TV, As Magnifier, And OCR Device

Dr. Bradley Gelfand (University of Virginia Center for Advanced Vision Science - Charlottesville, VA)

  

Vision Buddy (Dublin, CA)

Dr. Bradley Gelfand, assistant professor in the department of ophthalmology at the Center for Advanced Vision Science at the University of Virginia, explains how fluoxetine (Prozac) could possibly be repurposed to treat dry form of age-related macular degeneration.

Then, Zack Afridi, co-CEO and CSO of Vision Buddy, discusses how the electronic wearable goggles can be used to enhance the television watching experience, used as a magnifier, and used as an optical character recognition device.

11/14/2021 Podcast (Click Image Below) 

ViewPlus VP Rogue Braille Embosser with Tactile Graphics and CRISPR Used For Gene Editing To Treat Leber Congenital Amaurosis

VP Rogue (ViewPlus Technologies - Corvallis, OR)

Dr. Mark Pennesi (Casey Eye Institute, Oregon Health and Science University, Portland, OR)

Dan Gardner, CEO of ViewPlus Technologies, in Corvallis, Oregon, discusses the VP Rogue Sheet and Trac, which are braille embossers, capable of producing high resolution tactile graphics.

Then, Dr. Mark Pennesi, professor of ophthalmology, at Casey Eye Institute, at Oregon Health and Science University, in Portland, explains how a gene editing technique called, CRISPR, can be used to treat Leber Congenital Amaurosis.

10/31/2021 (Click Image Below) 

School-Based Vision For Baltimore Program and Treating Dry Eye with Eye Drops Derived From Corneal Epithelial Stem Cells

Dr. Megan Collins (Johns Hopkins University Wilmer Eye Institute - Baltimore, MD)

Dr. Hiranmoy Das (Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy - Amarillo, TX)

Dr. Megan Collins, an assistant professor of ophthalmology, at Johns Hopkins University Wilmer Eye Institute, discusses Vision for Baltimore, a city-wide program to expand school-based vision services for all students in grades pre-kindergarten through eighth grade in Baltimore City public schools. 

Then, Dr. Hiranmoy Das, a professor of pharmaceutical sciences, at Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy in Amarillo, explains how eye drops can be derived from corneal epithelial stem cells to treat severe dry eye disease.

10/24/2021 Podcast (Click Image Below)

Anesthetizing Good Eye To Strengthen Bad Eye In Amblyopia and 3D Color Camera and Auditory Cues Used With Robotic Canes

Dr. Mark Bear (Massachusetts Institute of Technology - Cambridge, MA)

Image courtesy of Cang Ye (Virginia Commonwealth University - Richmond, VA)

Dr. Mark Bear, Picower Professor of Neuroscience in the Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences at Massachusetts Institute of Technology, explains how anesthetizing the "good" eye in amblyopia for a short period of time in different species of mammals can help treat strengthen the amblyopic eye.

Dr. Cang Ye, professor of computer science, in the Virginia Commonwealth University College of Engineering, discusses how a robotic cane uses a 3D color camera, on-board computer, and inertial measurement sensor to guide users.

 09/19/2021 Podcast (Click Image Below)

Study Showing Most Vulnerable For Visual Impairment and Five Dimensions of Age-Related Macular Degeneration

Dr. David Rein (National Opinion Research Center - NORC - Chicago, IL)

Image courtesy of University of Alabama at Birmingham Department of Ophthalmology and Visual Sciences

Dr. David Rein, Director of the Public Health Analytics Program, with the National Opinion Research Center (NORC) at the University of Chicago goes over a study showing by age, sex, ethnicity, and region those, who are the most vulnerable for developing visual impairment.

Then, Dr. Christine Curcio, White-McKee Endowed Professor in Ophthalmology with the University of Alabama at Birmingham Department of Ophthalmology and Visual Sciences, explains how the "five dimensions" of age-related macular degeneration can lead to new therapeutic strategies.

9/12/2021 Podcast (Click Image Below) 

Role Of Variant of HtrA1 Protein In AMD And How Eye And Brain Work Together To Predict Movement Of Objects

Dr. Brandi Williams (University of Utah John A. Moran Eye Center - Salt Lake City, UT)

Dr. Michael Manookin (University of Washington School of Medicine - Seattle, WA)

Dr. Brandi Williams, director of research and science at Sharon Eccles Steele Center for Translational Medicine at the John A. Moran Eye Center at the University of Utah, explains how a variation of the HtrA1 protein plays a role in the development of age-related macular degeneration.

Then, Dr. Michael Manookin, an assistant professor of ophthalmology, at the University of Washington School of Medicine Department of Ophthalmology, discusses how the cones, bipolar cells, and ganglion cells work together with the brain to predict the path of moving objects.

8/22/2021 Podcast (Click Image Below)